4D Molecular Therapeutics (FDMT) Selling, General & Administrative (2020 - 2026)
4D Molecular Therapeutics (FDMT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -355.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 101.25 Mn |
| 10 | 4D Molecular Therapeutics | 691.54 Mn | 300.64 Mn | - | 11.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.69 Mn |
| Dec 31, 2025 | 12.77 Mn |
| Sep 30, 2025 | 11.84 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Mar 31, 2025 | 12.94 Mn |
| Dec 31, 2024 | 13.03 Mn |
| Sep 30, 2024 | 12.65 Mn |
| Jun 30, 2024 | 10.60 Mn |
| Mar 31, 2024 | 10.29 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Jun 30, 2023 | 8.79 Mn |
| Mar 31, 2023 | 7.99 Mn |
| Dec 31, 2022 | 8.47 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Mar 31, 2022 | 8.23 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 8.19 Mn |
| Jun 30, 2021 | 6.95 Mn |